Cardiovascular Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• asthma (1)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• emesis (6)

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

• glioma (9)

H

• health-care (1)

• hiv (7)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• liver (2)

• lung-cancer (2)

• lupus (1)

M

• memory (3)

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nausea (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pain (29)

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

• skin (1)

• sports (3)

T

• thc (1)

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)
  • Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (2010)

    This is the first study to demonstrate an antiarrhythmic effect of cannabidiol (CBD) after myocardial ischemia and reperfusion (I / R), and it is also the first to demonstrate that acute administration of a single dose of CBD is sufficient to reduce myocardial tissue injury, regardless of whether it is administered before or after coronary occlusion. Although more detailed studies are required to elucidate the mechanism by which CBD conserves tissue in I / R, this data extends to the currently very limited literature that details the role of CBD in the cardiovascular system and firmly establishes its potential as an cardioprotective agent. View study

  • Blood pressure regulation by endocannabinoids and their receptors (2005)

    This research focuses on analyzing the in vivo hypotensive and cardiodepressant effects of cannabinoids mediated by cannabinoid and TRPV1 receptors and new therapeutic strategies related to the treatment of hypertension. View study

  • Cannabinoids in experimental stroke: a systematic review and meta-analysis (2014)

    This research will be based on the analysis of cannabinoids (CB) and their incidence in preclinical stroke. It was observed in this study that the CB significantly reduced the infarct volume and improved the functional outcome in the experimental stroke. View study

  • Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries (2014)

    In this research, we intend to study the vasorelaxant effect of 2-arachidonoylglycerol (2-AG) in human mesenteric arteries. Through the results, it was demonstrated for the first time that 2-AG causes vasorelaxation of the human mesenteric arteries View study

  • Is the cardiovascular system a therapeutic target for cannabidiol? (2012)

    Cannabidiol, in addition to its beneficial effects in many disorders, can also be important for the treatment of cardiovascular diseases, since it acts directly on the isolated arteries and causes vasorelaxation. View study

  • Role of Endocannabinoids and Cannabinoid-1 Receptors in Cerebrocortical Blood Flow Regulation (2013)

    Endocannabinoids (EC) are endogenous bioactive lipid mediators that exert many of their effects in mammals through their receptors coupled to specific G proteins [1]. The present research aims to study the role of endocannabinoids and cannabinoid-1 receptors in the regulation of cerebrocortical blood flow View study

  • STUDIES INVESTIGATING THE MECHANISMS OF THE CARDIOPROTECTIVE EFFECTS OF CANNABIDIOL (2010)

    Heart and circulatory system diseases are generically known as cardiovascular diseases (CVD). This research study focused on better understanding the pharmacology of phytocannabinoid cannabidiol (CBD) by evaluating the hemodynamic responses to CBD and other cannabinoids using rats . View study

  • Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke (2010)

    This research aims to discuss the therapeutic possibility of cannabidiol (CBD), as a cerebroprotective agent, highlighting pharmacological advances, new mechanisms and the therapeutic time window of the (CBD) in ischemic stroke View study